The effects of diabetes mellitus on coronary artery bypass graft surgery

Current Diabetes Reports

Volumn 7, Issue 1, 2007, Pages 20-24

  Leavitt, Bruce J ^a  

^a FLETCHER ALLEN HEALTH CARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE PLUS INSULIN PLUS POTASSIUM; INSULIN; UNCLASSIFIED DRUG;

AWARENESS; CONTINUOUS INFUSION; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; DIABETES CONTROL; DIABETES MELLITUS; GLYCEMIC INDEX; GRAFT PATENCY; HUMAN; INCIDENCE; INTRAOPERATIVE PERIOD; LONG TERM CARE; MORTALITY; PERIOPERATIVE PERIOD; PREVALENCE; REVIEW; RISK FACTOR; SURVIVAL TIME; WOUND INFECTION;

CORONARY ARTERY BYPASS; DIABETES MELLITUS; GLUCOSE; HUMANS; PERIOPERATIVE CARE; PREVALENCE; SURVIVAL RATE;

EID: 33847347384     PISSN: 15344827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11892-007-0005-7     Document Type: Review

References (28)

1. American Heart Association: Cardiovascular Procedures - Statistics, 2004. Available at http://www.americanheart.org/downloadable/heart/ 1136820889417CardiovascularProc06.pdf. Accessed November 6, 2006.
2. American Diabetes Association: Total Prevalence of Diabetes & Pre-diabetes. Available at http://www.diabetes.org/diabetes-statistics/ prevalence.jsp. Accessed November 6, 2006.
3. Whang W, Bigger JT Jr: Diabetes and outcomes of coronary artery bypass graft surgery in patients with severe left ventricular dysfunction: results from The CABG Patch Trial database. The CABG Patch Trial Investigators and Coordinators. J Am Coll Cardiol 2000, 36:1166-1172.
4. Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI) [no authors listed]. Circulation 1997, 96:1761-1769.
5. Sedlis SP, Morrison DA, Lorin JD, et al.: Percutaneous coronary intervention versus coronary bypass graft surgery for diabetic patients with unstable angina and risk factors for adverse outcomes with bypass: outcome of diabetic patients in the AWESOME randomized trial and registry. J Am Coll Cardiol 2002, 40:1555-1566.
6. Leavitt BJ, Sheppard L, Maloney C, et al.: Effect of diabetes and associated conditions on long-term survival after coronary artery bypass graft surgery. Circulation 2004, 110(11 suppl 1):II41-II44.
7. Lilienfeld DE, Vlahov D, Tenney JH, McLaughlin JS: Obesity and diabetes as risk factors for postoperative wound infections after cardiac surgery. Am J Infect Control 1988, 16:3-6.
8. Braxton JH, Martin CA, McGrath PD, et al.: Mediastinitis and long-term survival after coronary artery bypass graft surgery. Ann Thorac Surg 2000, 70:2004-2007.
9. Loop FD, Lytle BW, Cosgrove DM, et al.: Sternal wound complications after isolated coronary artery bypass grafting: early and late mortality, morbidity, and cost of care. Ann Thorac Surg 1990, 49:179-186.
10. Grossi EA, Esposito R, Harris LJ, et al.: Sternal wound infections and use of internal mammary artery grafts. J Thorac Cardiovasc Surg 1991, 102:342-346; discussion 346-347.
11. Matsa M, Paz Y, Gurevitch J, et al.: Bilateral skeletonized internal thoracic artery grafts in patients with diabetes mellitus. J Thorac Cardiovasc Surg 2001, 121:668-674.
12. Edwards FH, Grover FL, Shroyer ALW, et al.: The Society of Thoracic Surgeons National Cardiac Surgery Database: current risk assessment. Ann Thorac Surg 1997, 63:903-908.
13. Clough RA, Leavitt BJ, Morton JR, et al.: The effect of comorbid illness on mortality outcomes in cardiac surgery. Arch Surg 2002, 137:428-432; discussion 432-433.
14. Schwartz L, Kip KE, Frye RL, et al.: Coronary bypass graft patency in patients with diabetes in the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 2002, 106:2652-2658.
15. Detre KM, Lombardero MS, Brooks MM, et al.: The effect of previous coronary-artery bypass surgery on the prognosis of patients with diabetes who have acute myocardial infarction. Bypass Angioplasty Revascularization Investigation Investigators. N Engl J Med 2000 342:989-997.
16. Niles NW, McGrath PD, Malenka D, et al.: Survival of patients with diabetes and multivessel coronary artery disease after surgical or percutaneous coronary revascularizatiom results of a large regional prospective study. Northern New England Cardiovascular Disease Study Group J Am Coll Cardiol 2001, 37:1008-1015.
17. Weintraub WS, Stein B, Kosinski A, et al.: Outcome of coronary bypass surgery versus coronary angioplasty in diabetic patients with multivessel coronary artery disease. J Am Coll Cardiol 1998, 31:10-19.
18. Abizaid A, Costa MA, Centemero M, et al.: Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients: insights from the Arterial Revascularization Therapy Study (ARTS) trial. Circulation 2001, 104:533-538.
19. Flaherty JD, Davidson CJ: Diabetes and coronary revascularization. JAMA 2005, 293:1501-1508.
20. Zerr KJ, Furnary AP, Grunkemeier GL, et al.: Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg 1997, 63:356-361.
21. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A: Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 1999, 67:352-360; discussion 360-362.
22. Furnary AP, Gao G, Grunkemeier GL, et al.: Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 2003, 125:1007-1021.
23. O'Connor GT, Plume SK, Olmstead EM, et al.: A regional prospective study of in-hospital mortality associated with coronary artery bypass grafting. JAMA 1991, 266:803-809.
24. Lazar HL, Chipkin SR, Fitzgerald CA, et al.: Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation 2004, 109:1497-1502.
25. Leavitt BJ, O'Connor GT, Olmstead EM, et al.: Use of the internal mammary artery and in-hospital mortality and other adverse outcomes associated with coronary artery bypass surgery. Circulation 2001, 103:507-512.
26. Barsness GW, Peterson ED, Ohman EM, et al.: Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty. Circulation 1997, 96:2551-2556.
27. Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status [no authors listed]. J Am Coll Cardiol 2000, 35:1122-1129.
28. Thourani VH, Weintraub WS, Stein B, et al.: Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting. Ann Thorac Surg 1999, 67:1045-1052.